Evidence map›Paper›PMID 33228032›Full record

ReviewInternational journal of molecular sciences2020

High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma.

Vasily A Kudinov, Olga Yu Alekseeva, Tatiana I Torkhovskaya, Konstantin K Baskaev, Rafael I Artyushev, Irina N Saburina, Sergey S Markin

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Vasily A KudinovLaboratory of Cell Biology and Developmental Pathology, FSBSI Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.ORCID 0000-0003-2191-3899
Olga Yu AlekseevaCell Physiology Laboratory, Institute of Biomedical Problems, Russian Academy of Sciences, 123007 Moscow, Russia.ORCID 0000-0002-8498-2907
Tatiana I TorkhovskayaLaboratory of Phospholipid Transport Systems and Nanomedicines, Institute of Biomedical Chemistry, 119121 Moscow, Russia.ORCID 0000-0003-2154-3939
Konstantin K BaskaevExperimental Drug Research and Production Department, Institute of Biomedical Chemistry, 119121 Moscow, Russia.ORCID 0000-0003-1437-8656
Rafael I ArtyushevExperimental Drug Research and Production Department, Institute of Biomedical Chemistry, 119121 Moscow, Russia.ORCID 0000-0003-0481-2957
Irina N SaburinaLaboratory of Cell Biology and Developmental Pathology, FSBSI Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.ORCID 0000-0003-2014-2535
Sergey S MarkinClinical Research Department, Institute of Biomedical Chemistry, 119121 Moscow, Russia.ORCID 0000-0002-0242-0282
Institute of Biomedical Chemistry · RUResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUPeoples' Friendship University of Russia · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that blood lipoproteins (LPs) are multimolecular complexes of lipids and proteins that play a crucial role in lipid transport. High-density lipoproteins (HDL) are a class of blood plasma LPs that mediate reverse cholesterol transport (RCT)-cholesterol transport from the peripheral tissues to the liver. Due to this ability to promote cholesterol uptake from cell membranes, HDL possess antiatherogenic properties. This function was first observed at the end of the 1970s to the beginning of the 1980s, resulting in high interest in this class of LPs. It was shown that HDL are the prevalent class of LPs in several types of living organisms (from fishes to monkeys) with high resistance to atherosclerosis and cardiovascular disorders. Lately, understanding of the mechanisms of the antiatherogenic properties of HDL has significantly expanded. Besides the contribution to RCT, HDL have been shown to modulate inflammatory processes, blood clotting, and vasomotor responses. These particles also possess antioxidant properties and contribute to immune reactions and intercellular signaling. Herein, we review data on the structure and mechanisms of the pleiotropic biological functions of HDL from the point of view of their evolutionary role and complex dynamic nature.

Indexed as

AnimalsAnti-Infective AgentsAnti-Inflammatory AgentsAntioxidantsAtherosclerosisBiological TransportBlood CoagulationCholesterolHomeostasisHumansLipoproteins, HDLSignal TransductionVasodilator AgentsVasomotor SystemAnti-Infective AgentsAnti-Inflammatory AgentsAntioxidantsCholesterolLipoproteins, HDLVasodilator AgentsHDL functionshigh-density lipoproteinsreverse cholesterol transport

Identifiers

PMID33228032
PMCPMC7699323
OpenAlexW3103001760

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.